Altimmune, Inc.ALTNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -19.21% |
| 2024 | 24.97% |
| 2023 | -6.72% |
| 2022 | -5.37% |
| 2021 | 49.76% |
| 2020 | 180.17% |
| 2019 | -3.76% |
| 2018 | 0.29% |
| 2017 | 280.61% |
| 2016 | -5.79% |